Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

A Monoclonal Antibody to M-Phase Phosphoprotein 1/Kinesin-Like Protein KIF20B.

Fritzler MJ, Brown RD, Zhang M.

Monoclon Antib Immunodiagn Immunother. 2019 Jun 28. doi: 10.1089/mab.2019.0016. [Epub ahead of print]

PMID:
31260385
2.

Expression of a constitutively active human STING mutant in hematopoietic cells produces an Ifnar1-dependent vasculopathy in mice.

Martin GR, Henare K, Salazar C, Scheidl-Yee T, Eggen LJ, Tailor PP, Kim JH, Podstawka J, Fritzler MJ, Kelly MM, Yipp BG, Jirik FR.

Life Sci Alliance. 2019 Jun 20;2(3). pii: e201800215. doi: 10.26508/lsa.201800215. Print 2019 Jun.

3.

Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.

Goobie GC, Ford-Sahibzada CA, Fritzler MJ, Johannson KA, Fell CD.

Respir Med. 2019 Jul;153:85-90. doi: 10.1016/j.rmed.2019.05.019. Epub 2019 May 29.

PMID:
31176275
4.

Antinuclear antibodies by indirect immunofluorescence and solid phase assays.

Bossuyt X, Claessens J, De Langhe E, Belmondo T, Westhovens R, Hue S, Poesen K, Blockmans D, Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May 10. pii: annrheumdis-2019-215443. doi: 10.1136/annrheumdis-2019-215443. [Epub ahead of print] No abstract available.

PMID:
31076390
5.

Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells.

Yilmaz OK, Haeberle S, Zhang M, Fritzler MJ, Enk AH, Hadaschik EN.

Front Immunol. 2019 Apr 24;10:881. doi: 10.3389/fimmu.2019.00881. eCollection 2019.

6.

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.

Amlani A, Choi MY, Tarnopolsky M, Brady L, Clarke AE, Garcia-De La Torre I, Mahler M, Schmeling H, Barber CE, Jung M, Fritzler MJ.

Front Immunol. 2019 Apr 9;10:745. doi: 10.3389/fimmu.2019.00745. eCollection 2019.

7.

Establishment of an international autoantibody reference standard for human anti-DFS70 antibodies: proof-of-concept study for a novel Megapool strategy by pooling individual specific sera.

Dellavance A, Baldo DC, Zheng B, Mora RA, Fritzler MJ, Hiepe F, Rönnelid J, Satoh M, Garcia-De La Torre I, Wener MH, Chan EKL, Andrade LEC.

Clin Chem Lab Med. 2019 Apr 22. pii: /j/cclm.ahead-of-print/cclm-2019-0087/cclm-2019-0087.xml. doi: 10.1515/cclm-2019-0087. [Epub ahead of print]

PMID:
31005948
8.

The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.

Norman GL, Reig A, Viñas O, Mahler M, Wunsch E, Milkiewicz P, Swain MG, Mason A, Stinton LM, Aparicio MB, Aldegunde MJ, Fritzler MJ, Parés A.

Front Immunol. 2019 Apr 3;10:662. doi: 10.3389/fimmu.2019.00662. eCollection 2019.

9.

Prevalence of Auto-antibodies in Pulmonary Tuberculosis.

Cheng MP, Butler-Laporte G, Parkes LO, Bold TD, Fritzler MJ, Behr MA.

Open Forum Infect Dis. 2019 Mar 7;6(4):ofz114. doi: 10.1093/ofid/ofz114. eCollection 2019 Apr.

10.

Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy.

Richards M, García-De La Torre I, González-Bello YC, Vázquez-Del Mercado M, Andrade-Ortega L, Medrano-Ramírez G, Navarro-Zarza JE, Maradiaga-Ceceña M, Loyo E, Rojo-Mejía A, Gómez G, Seaman A, Fritzler MJ, Koenig M, Mahler M.

Rheumatology (Oxford). 2019 Apr 1. pii: kez092. doi: 10.1093/rheumatology/kez092. [Epub ahead of print]

PMID:
30938432
11.

Implications for redefining the dense fine speckled and related indirect immunofluorescence patterns.

Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ.

Expert Rev Clin Immunol. 2019 May;15(5):447-448. doi: 10.1080/1744666X.2019.1596802. Epub 2019 Mar 29. No abstract available.

PMID:
30880500
12.

Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.

Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia de la Torre I, Herold M, Klotz W, Cruvinel WM, Mimori T, von Muhlen C, Satoh M, Chan EK.

Ann Rheum Dis. 2019 Jul;78(7):879-889. doi: 10.1136/annrheumdis-2018-214436. Epub 2019 Mar 12.

13.

A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis.

Sporinova B, McRae SA, Muruve DA, Fritzler MJ, Nasr SH, Chin AC, Benediktsson H.

BMC Nephrol. 2019 Jan 31;20(1):29. doi: 10.1186/s12882-019-1227-z.

14.

Anti-DFS70 antibodies: an update on our current understanding and their clinical usefulness.

Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ.

Expert Rev Clin Immunol. 2019 Mar;15(3):241-250. doi: 10.1080/1744666X.2019.1562903. Epub 2019 Feb 4.

PMID:
30623687
15.

The Utilization of Autoantibodies in Approaches to Precision Health.

Fritzler MJ, Martinez-Prat L, Choi MY, Mahler M.

Front Immunol. 2018 Nov 16;9:2682. doi: 10.3389/fimmu.2018.02682. eCollection 2018.

16.

Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts.

Pfau JC, Barbour C, Black B, Serve KM, Fritzler MJ.

J Toxicol Environ Health A. 2018;81(19):1015-1027. doi: 10.1080/15287394.2018.1512432. Epub 2018 Sep 19.

PMID:
30230971
17.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712. Epub 2019 Jun 12.

PMID:
30044551
18.

A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.

Nguyen HH, Khathlan A, Fritzler MJ, Swain MG.

BMC Gastroenterol. 2018 Jun 25;18(1):97. doi: 10.1186/s12876-018-0826-7.

19.

Redefining systemic lupus erythematosus - SMAARTT proteomics.

Fritzler MJ, Mahler M.

Nat Rev Rheumatol. 2018 Aug;14(8):451-452. doi: 10.1038/s41584-018-0035-3. No abstract available.

PMID:
29907860
20.

International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I.

Andrade LEC, Klotz W, Herold M, Conrad K, Rönnelid J, Fritzler MJ, von Mühlen CA, Satoh M, Damoiseaux J, de Melo Cruvinel W, Chan EKL; Executive Committee of ICAP.

Clin Chem Lab Med. 2018 Sep 25;56(10):1783-1788. doi: 10.1515/cclm-2018-0188. No abstract available.

21.

The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination.

Mummert E, Fritzler MJ, Sjöwall C, Bentow C, Mahler M.

J Immunol Methods. 2018 Aug;459:11-19. doi: 10.1016/j.jim.2018.05.014. Epub 2018 May 26. Review.

PMID:
29807021
22.

Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

Meroni PL, Chan EK, Damoiseaux J, Andrade LEC, Bossuyt X, Conrad K, Mariette X, Sheldon J, Rönnelid J, Fritzler MJ; members of the committees.

Ann Rheum Dis. 2019 Jun;78(6):e46. doi: 10.1136/annrheumdis-2018-213440. Epub 2018 Apr 17. No abstract available.

PMID:
29666046
23.

International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns.

Herold M, Klotz W, Andrade LEC, Conrad K, de Melo Cruvinel W, Damoiseaux J, Fritzler MJ, von Muhlen CA, Satoh M, Chan EKL.

Clin Chem Lab Med. 2018 Sep 25;56(10):1799-1802. doi: 10.1515/cclm-2018-0052. No abstract available.

PMID:
29634478
24.

Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).

Nguyen HH, Shaheen AA, Baeza N, Lytvyak E, Urbanski SJ, Mason AL, Norman GL, Fritzler MJ, Swain MG.

PLoS One. 2018 Mar 19;13(3):e0193960. doi: 10.1371/journal.pone.0193960. eCollection 2018.

25.

Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.

Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Mahler M, Fritzler MJ, Bossuyt X.

Autoimmun Rev. 2018 Jun;17(6):533-540. doi: 10.1016/j.autrev.2018.03.002. Epub 2018 Mar 8. Review.

PMID:
29526634
26.

The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.

Fritzler MJ, Choi MY, Mahler M.

J Rheumatol. 2018 Mar;45(3):444-445. doi: 10.3899/jrheum.170258. No abstract available.

PMID:
29496922
27.

Diagnostic Utility of Anticarbamylated Protein Antibodies as Measured Using Carbamylated Fetal Calf Serum.

Mahler M, Fritzler MJ.

J Rheumatol. 2018 Mar;45(3):438-439. doi: 10.3899/jrheum.170677. No abstract available.

PMID:
29496917
28.

Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.

Calise SJ, Zheng B, Hasegawa T, Satoh M, Isailovic N, Ceribelli A, Andrade LEC, Boylan K, Cavazzana I, Fritzler MJ, de la Torre IG, Hiepe F, Kohl K, Selmi C, Shoenfeld Y, Tincani A, Chan EKL; IUIS Autoantibody Standardization Committee.

Clin Chem Lab Med. 2018 Sep 25;56(10):1789-1798. doi: 10.1515/cclm-2017-1152. No abstract available.

PMID:
29478040
29.

Detection of myositis-specific antibodies: additional notes.

Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May;78(5):e45. doi: 10.1136/annrheumdis-2018-213153. Epub 2018 Feb 14. No abstract available.

PMID:
29444906
30.

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.

Fritzler MJ, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M; Canadian Scleroderma Research Group.

Autoimmun Rev. 2018 Mar;17(3):267-275. doi: 10.1016/j.autrev.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29369808
31.

Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy.

Amlani A, Hazlewood GS, Hamilton L, Satoh M, Fritzler MJ.

Rheumatology (Oxford). 2018 Jan 1;57(1):199-200. doi: 10.1093/rheumatology/kex392. No abstract available.

32.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM, Rich E, Boudabbouz H, Bourré-Tessier J, Albert M, Goulet JR, Landry M, Senécal JL.

Scand J Rheumatol. 2018 May;47(3):210-224. doi: 10.1080/03009742.2017.1334814. Epub 2017 Oct 25.

PMID:
29065773
33.

Emerging technologies in autoantibody testing for rheumatic diseases.

Olsen NJ, Choi MY, Fritzler MJ.

Arthritis Res Ther. 2017 Jul 24;19(1):172. doi: 10.1186/s13075-017-1380-3. Review.

34.

CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.

Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, Agarwal SK, Hudson M, Pope J, Zhou X, Reveille JD, Fritzler MJ, Mayes MD, Assassi S.

Arthritis Rheumatol. 2017 Sep;69(9):1871-1878. doi: 10.1002/art.40171. Epub 2017 Aug 8.

35.

Industrial air emissions, and proximity to major industrial emitters, are associated with anti-citrullinated protein antibodies.

Bernatsky S, Smargiassi A, Joseph L, Awadalla P, Colmegna I, Hudson M, Fritzler MJ.

Environ Res. 2017 Aug;157:60-63. doi: 10.1016/j.envres.2017.04.035. Epub 2017 May 17.

PMID:
28525857
36.

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Buyon J, Mahler M, Fritzler MJ.

Lupus. 2017 Sep;26(10):1051-1059. doi: 10.1177/0961203317692437. Epub 2017 Feb 23.

PMID:
28420054
37.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ; Canadian Scleroderma Research Group; Australian Scleroderma Cohort Study; Genetics versus Environment in Scleroderma Outcome Study.

J Rheumatol. 2017 Jun;44(6):799-805. doi: 10.3899/jrheum.160574. Epub 2017 Apr 1.

38.

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.

Li G, Adachi JD, Cheng J, Thabane L, Hudson M, Fritzler MJ, Lorenzi S, Baron M, Larché M; Canadian Scleroderma Research Group.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):56-60. Epub 2017 Jan 31.

PMID:
28229818
39.

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL.

Medicine (Baltimore). 2017 Jan;96(3):e5694. doi: 10.1097/MD.0000000000005694.

40.

Anti-HMGCR antibodies in systemic sclerosis.

Hudson M, Luck Y, Stephenson M, Choi MY, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Medicine (Baltimore). 2016 Nov;95(44):e5280.

41.

Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.

Zheng B, Vincent C, Fritzler MJ, Senécal JL, Koenig M, Joyal F.

J Rheumatol. 2017 Jan;44(1):33-39. doi: 10.3899/jrheum.160243. Epub 2016 Oct 15.

PMID:
27744398
42.

Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M.

Rheumatology (Oxford). 2016 Dec;55(12):2148-2155. Epub 2016 Sep 4.

43.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Medicine (Baltimore). 2016 Aug;95(35):e4713. doi: 10.1097/MD.0000000000004713.

44.

Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.

Fritzler MJ, Chan EKL.

Lupus. 2017 Feb;26(2):208-217. doi: 10.1177/0961203316664598. Epub 2016 Aug 20.

PMID:
27539991
45.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
46.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

47.

Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey.

Bentow C, Fritzler MJ, Mummert E, Mahler M.

Auto Immun Highlights. 2016 Dec;7(1):8. doi: 10.1007/s13317-016-0081-2. Epub 2016 Jul 9.

48.

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.

Choi MY, Fritzler MJ.

Curr Opin Rheumatol. 2016 Nov;28(6):586-94. doi: 10.1097/BOR.0000000000000325. Review.

49.

Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.

Bentow C, Rosenblum R, Correia P, Karayev E, Karayev D, Williams D, Kulczycka J, Fritzler MJ, Mahler M.

Lupus. 2016 Jul;25(8):897-904. doi: 10.1177/0961203316641773.

PMID:
27252267
50.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.

Mahler M, Swart A, Wu J, Szmyrka-Kaczmarek M, Senécal JL, Troyanov Y, Hanly JG, Fritzler MJ.

Lupus. 2016 Jul;25(8):889-96. doi: 10.1177/0961203316640918.

PMID:
27252266

Supplemental Content

Loading ...
Support Center